Halodoc Closes Series C Funding Round Worth 1.1 Trillion Rupiah

On its 5th anniversary (21/4), Halodoc announced the closing of $80 million (around 1.1 trillion Rupiah) series C funding round led by Astra International, with participation of Temasek, Telkomsel Mitra Inovasi, Novo Holdings, Acrew Diversify Capital Fund, and Bangkok Bank. There are some previous investors involved, including UOB Venture Management, Singtel Innov8, Blibli Group, Allianz X, Openspace Ventures, and others.

In the official release, this funding is said to be allocated to expand Halodoc's penetration in various major health verticals as well as improve user experience through technology. Previously, Halodoc's Co-Founder & CEO, Jonathan Sudharta had expressed his ambition for regional expansion, bringing practice from Indonesia to the targeted countries.

Djony Bunarto Tjondro as President Director of Astra said, “Astra's participation in the Halodoc fundraising shows our confidence in Halodoc's vision and commitment in overcoming challenges related to access to health services in Indonesia. The pandemic that has occurred to date is very challenging for the national health service system and we believe the investment made by Astra can support Halodoc to continue to provide innovative solutions that can benefit the lives of millions of Indonesians. "